Cargando…

Assessing quality of life on the day of chemotherapy administration underestimates patients’ true symptom burden

BACKGROUND: In chemotherapy trials quality of life (QOL) is assessed mostly at the days of chemotherapy administration (i.e. event-driven) during treatment and follows fixed time intervals in the aftercare phase (i.e. time-driven). Specific QOL impairments and treatment side-effects are known to be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giesinger, Johannes M, Wintner, Lisa M, Zabernigg, August, Gamper, Eva-Maria, Oberguggenberger, Anne S, Sztankay, Monika J, Kemmler, Georg, Holzner, Bernhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198707/ https://www.ncbi.nlm.nih.gov/pubmed/25305067 http://dx.doi.org/10.1186/1471-2407-14-758

Ejemplares similares

Quality of life across chemotherapy lines in patients with cancers of the pancreas and biliary tract
por: Zabernigg, August, et al.
Publicado: (2012)

Evaluation of electronic patient-reported outcome assessment with cancer patients in the hospital and at home
por: Wintner, L. M., et al.
Publicado: (2015)

Quality of life during chemotherapy in lung cancer patients: results across different treatment lines
por: Wintner, L M, et al.
Publicado: (2013)

Adherence evaluation of endocrine treatment in breast cancer: methodological aspects
por: Oberguggenberger, Anne S, et al.
Publicado: (2012)

The Computer-based Health Evaluation Software (CHES): a software for electronic patient-reported outcome monitoring
por: Holzner, Bernhard, et al.
Publicado: (2012)

Evaluating the use of the EORTC patient-reported outcome measures for improving inter-rater reliability of CTCAE ratings in a mixed population of cancer patients: study protocol for a randomized controlled trial
por: Wintner, Lisa M., et al.
Publicado: (2020)

Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting
por: Sztankay, Monika, et al.
Publicado: (2017)

Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapy
por: Meraner, Verena, et al.
Publicado: (2012)

Normative data for the EORTC QLQ-C30 from the Austrian general population
por: Lehmann, Jens, et al.
Publicado: (2020)

Development of an item bank for the EORTC Role Functioning Computer Adaptive Test (EORTC RF-CAT)
por: Gamper, Eva-Maria, et al.
Publicado: (2016)

Cross-cultural development of an item list for computer-adaptive testing of fatigue in oncological patients
por: Giesinger, Johannes M, et al.
Publicado: (2011)

Does the toxicity of endocrine therapy persist into long-term survivorship?: Patient-reported outcome results from a follow-up study beyond a 10-year-survival
por: Carmen, Albertini, et al.
Publicado: (2022)

Using the Computer-based Health Evaluation System (CHES) to Support Self-management of Symptoms and Functional Health: Evaluation of Hematological Patient Use of a Web-Based Patient Portal
por: Lehmann, Jens, et al.
Publicado: (2021)

Self-reported sexual health: Breast cancer survivors compared to women from the general population – an observational study
por: Oberguggenberger, Anne, et al.
Publicado: (2017)

Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme
por: Gamper, Eva-Maria, et al.
Publicado: (2015)

Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional functioning, fatigue and pain
por: Giesinger, Johannes M., et al.
Publicado: (2016)

The EORTC emotional functioning computerized adaptive test: phases I–III of a cross-cultural item bank development
por: Gamper, Eva-Maria, et al.
Publicado: (2014)

How to implement routine electronic patient‐reported outcome monitoring in oncology rehabilitation
por: Wintner, Lisa M., et al.
Publicado: (2020)

International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26
por: Sztankay, Monika, et al.
Publicado: (2018)

We are underestimating, again, the true burden of H5N1 in humans
por: Gomaa, Mokhtar, et al.
Publicado: (2023)

PRO Hair Safe Study: The Patient’s Perspective on the Effects of Scalp Cooling on Hair Preservation
por: Brunner, Christine, et al.
Publicado: (2023)

Functional health and symptoms in Spain before and during the COVID-19 pandemic
por: Lehmann, Jens, et al.
Publicado: (2021)

Can we use gonadotropin plasma concentration as surrogate marker for BMI-related incomplete estrogen suppression in breast cancer patients receiving anastrozole?
por: Oberguggenberger, A., et al.
Publicado: (2017)

German value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30
por: Kemmler, Georg, et al.
Publicado: (2019)

Correction to: do patients consider computer-adaptive measures more appropriate than static questionnaires?
por: Gamper, Eva-Maria, et al.
Publicado: (2019)

Do patients consider computer-adaptive measures more appropriate than static questionnaires?
por: Gamper, Eva-Maria, et al.
Publicado: (2019)

Estimation of an EORTC QLU-C10 Value Set for Spain Using a Discrete Choice Experiment
por: Finch, Aureliano Paolo, et al.
Publicado: (2021)

The EORTC QLU-C10D discrete choice experiment for cancer patients: a first step towards patient utility weights
por: Gamper, Eva-Maria, et al.
Publicado: (2022)

Complementing clinical cancer registry data with patient reported outcomes: A feasibility study on routine electronic patient‐reported outcome assessment for the Austrian Myelome Registry
por: Sztankay, Monika, et al.
Publicado: (2019)

Systematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumours
por: Martini, Caroline, et al.
Publicado: (2016)

Dutch utility weights for the EORTC cancer-specific utility instrument: the Dutch EORTC QLU-C10D
por: Jansen, Femke, et al.
Publicado: (2021)

Do neurooncological patients and their significant others agree on quality of life ratings?
por: Giesinger, Johannes M, et al.
Publicado: (2009)

Improvement of quality of life and psychological distress after inpatient cancer rehabilitation: Results of a longitudinal observational study
por: Riedl, David, et al.
Publicado: (2017)

Development Of A Computer-Adaptive Version Of The Forgotten Joint Score
por: Giesinger, Johannes M., et al.
Publicado: (2013)

Influence of a Structured Exercise Training on Patients Reported Quality of Life in Colorectal Cancer Patients After Adjuvant Chemotherapy: A Pilot Study
por: Piringer, Gudrun, et al.
Publicado: (2020)

General population normative data from seven European countries for the K10 and K6 scales for psychological distress
por: Lehmann, J., et al.
Publicado: (2023)

Development of an item list to assess the forgotten joint concept in shoulder patients
por: Giesinger, Johannes M, et al.
Publicado: (2015)

Patients’ and health professionals’ understanding of and preferences for graphical presentation styles for individual-level EORTC QLQ-C30 scores
por: Kuijpers, W., et al.
Publicado: (2015)

Adherence to Patient-Reported Symptom Monitoring and Subsequent Clinical Interventions for Patients With Multiple Myeloma in Outpatient Care: Longitudinal Observational Study
por: Lehmann, Jens, et al.
Publicado: (2023)

2254. Asymptomatic Bacteriuria Underestimates True Inappropriate Prescribing for Non-Urinary Tract Infections
por: Hartlage, Whitney, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g7rvtlq5jrofq9hidoa3d5crp8